Snoring in Young Children Linked to Behavioral Problems
Persistent, loud snoring in young children aged 2-3 years is associated with higher rates of behavior problems.
Diagnosis & Disease Information
Mylan Launches Generic Provigil
Mylan announced the launch of Modafinil Tablets, the generic version of Cephalon’s Provigil tablets.
Healthy Media Leads to Fewer Sleep Problems for Children
Healthy media with educational and prosocial content leads to fewer sleep problems for children aged 3-5 years, compared with violent or age-inappropriate media.
Cortical Surface Area Maturation Delayed in ADHD
Compared with typically developing children, cortical surface area development is delayed in those with attention-deficit/hyperactivity disorder (ADHD).
Wide Range of Accuracy in Web-Based Infant Sleep Advice
The accuracy of infant sleep recommendations found on the Internet varies by search terms used and type of Web site.
Teva Launches Generic Ritalin LA
Teva announced the launch of Methylphenidate HCl Extended-Release Capsules LA, the generic version of Novartis’ Ritalin LA Capsules.
Prenatal Caffeine Intake Not Linked to Children’s Behavior
Maternal prenatal caffeine intake is not associated with behavior problems in young children.
Actavis Approved for Generic Intuniv Tablets
Actavis announced that the FDA has granted tentative approval for Guanfacine Extended-release Tablets, the generic of Shire’s Intuniv tablets.
Early Start to ADHD Meds Lowers Risk of Academic Decline
Earlier initiation of stimulant treatment for attention-deficit/hyperactivity disorder (ADHD) is associated with a lower risk of decline in academic performance.
Actavis Approved for Generic Adderall XR
Actavis announced that it has received approval from the FDA to market Mixed Amphetamine Salts ER (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release) capsules, the generic version of Shire’s Adderall XR capsules.
